Work

Circulating tumor DNA monitoring in ovarian cancer patients receiving PARPi maintenance therapy: Can we further personalize treatment?

Year: 2025

Type: article

Study design: Observational Study

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2025.11.005

Authors: Michael D. Toboni, Elizabeth T. Evans, Carly Bess Scalise, Melissa Hardesty, Tara Berman, Kaitlyn Dinkins, Fibiana Oladipo, Nicole Hook, Jenifer Ferguson, Punashi Dutta, Jennah Moore, Bailee Oliver, Minetta C. Liu, Adam C. ElNaggar, Charles A. Leath, Rebecca C. Arend

Institutions: University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center, Mercy Hospital, Natera (United States), Alaska Women's Cancer Care, Dana-Farber Cancer Institute

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Universitat Autònoma de Barcelona

OpenAlex ID: W4416412004

FWCI: 2.875

Cites: 16

Cited by: 7

Related to: 10